InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Mark J Foley, CEO, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 9 open-market SEC Form 4 transactions: 2 purchases worth $725K and 7 sales worth $9.8M, reported from Nov 29, 21 to Feb 26, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 25 | GKOSGLAUKOS Corp | SELL | 20.7K | $120.72 | $2.5M |
| Mar 6, 24 | RVNCRevance Therapeutics, Inc. | BUY | 30.0K | $6.98 | $209K |
| Feb 23, 24 | GKOSGLAUKOS Corp | SELL | 4.6K | $92.87 | $423K |
| Aug 3, 23 | RVNCRevance Therapeutics, Inc. | SELL | 26.3K | $22.57 | $593K |
| Jul 3, 23 | RVNCRevance Therapeutics, Inc. | SELL | 26.3K | $24.94 | $655K |
| Jun 9, 23 | RVNCRevance Therapeutics, Inc. | SELL | 31.3K | $30.72 | $961K |
| May 15, 23 | RVNCRevance Therapeutics, Inc. | SELL | 70.4K | $34.55 | $2.4M |
| Mar 9, 23 | RVNCRevance Therapeutics, Inc. | SELL | 70.4K | $31.59 | $2.2M |
| Nov 29, 21 | RVNCRevance Therapeutics, Inc. | BUY | 40.0K | $12.90 | $516K |